Julia Marie Eastland - Dec 2, 2024 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
CEO & President, Director
Signature
/s/ Andrea Paul, attorney-in-fact for Julia Marie Eastland
Stock symbol
ZNTL
Transactions as of
Dec 2, 2024
Transactions value $
$0
Form type
4
Date filed
12/3/2024, 07:02 PM
Previous filing
Nov 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZNTL Stock Option (Right to Buy) Award $0 +3.03M $0.00 3.03M Dec 2, 2024 Common Stock 3.03M $3.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest over a four-year period following the vesting commencement date of November 13, 2024, in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.